Startup Street: Early learning platform Kutuki raises seed funding of Rs 16 crore-March 2024-www.financetom.com

Startup Street: Early learning platform Kutuki raises seed funding of Rs 16 crore

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Startup Street: Early learning platform Kutuki raises seed funding of Rs 16 crore

Feb 24, 2021 11:03 AM

Early learning platform Kutuki has raised a seed round of Rs 16 crore led by Omidyar Network India. Launched in 2019 by Bengaluru-based couple, Sneha and Bharath, Kutuki's interactive learning app is built on a proprietary story and rhyme-based curriculum focusing on language, life skills, stem and general knowledge.

Startup Street spoke to Bharath Bevinahally, co-founder & CEO of Kutuki, to discuss the road ahead for the company.

Also watch Startup Street in conversation with Pankaj Makkar, MD of Bertelsmann India Investments, who spoke about the future of D2C or direct to consumer startups in India.

Watch video for more.

(Edited by : Bivekananda Biswas)

Previous page： S&T Bancorp Earnings, Revenue Decline in Q3 Next page： Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

S&T Bancorp Earnings, Revenue Decline in Q3

Oct 17, 2024

08:04 AM EDT, 10/17/2024 (MT Newswires) -- S&T Bancorp ( STBA ) reported Q3 earnings Thursday of $0.85 per diluted share, down from $0.87 a year earlier. Five analysts polled by Capital IQ expected $0.81. Revenue for the quarter, expressed as the sum of net interest income and total noninterest income, was $96.4 million, compared with $99.6 million a year...

Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab

Oct 17, 2024

08:06 AM EDT, 10/17/2024 (MT Newswires) -- Theratechnologies ( THTX ) on Thursday announced the study design and baseline characteristics of participants in a prospective observational study of multidrug-resistant patient outcomes with and without the company's ibalizumab in a real-world setting in the U.S. (PROMISE-US). The study seeks to fill a gap in long-term clinical outcomes for heavily treatment-experienced people...

BMO on The Day Ahead in Canada

Oct 17, 2024

08:02 AM EDT, 10/17/2024 (MT Newswires) -- The calendar is light in Canada on Thursday, with no market-moving pieces of macroeconomic data on deck, noted Bank of Montreal (BMO). Investors will get construction investment and international securities transactions, both for August, at 8:30 a.m ET, said the bank. The Canadian dollar (CAD or loonie) softened again on Thursday at $1.378/USD...

Wipro's Fiscal Q2 Earnings Rise, Revenue Falls

Oct 17, 2024

08:05 AM EDT, 10/17/2024 (MT Newswires) -- Wipro ( WIT ) reported fiscal Q2 earnings Thursday of 6.12 Indian rupees ($0.07) per diluted share, up from 5.04 Indian rupees a year earlier. One analyst polled by Capital IQ expected 5.55 Indian rupees. Revenue for the quarter ended Sept. 30 was 223.02 billion Indian rupees compared with 225.16 billion Indian rupees...